Published in Int Immunol on April 01, 2001
Killer artificial antigen-presenting cells: a novel strategy to delete specific T cells. Blood (2007) 1.01
Fn14-TRAIL, a chimeric intercellular signal exchanger, attenuates experimental autoimmune encephalomyelitis. Am J Pathol (2009) 0.90
Targeting the B7 family of co-stimulatory molecules: successes and challenges. BioDrugs (2013) 0.89
CD40·FasL and CTLA-4·FasL fusion proteins induce apoptosis in malignant cell lines by dual signaling. Am J Pathol (2010) 0.78
Highly efficient, in-vivo Fas-mediated apoptosis of B-cell lymphoma by hexameric CTLA4-FasL. J Hematol Oncol (2014) 0.78
A recombinant scFv-FasLext as a targeting cytotoxic agent against human Jurkat-Ras cancer. J Biomed Sci (2013) 0.77
Enhancing production and cytotoxic activity of polymeric soluble FasL-based chimeric proteins by concomitant expression of soluble FasL. PLoS One (2013) 0.76
Prolongation of corneal allograft survival by CTLA4-FasL in a murine model. Graefes Arch Clin Exp Ophthalmol (2007) 0.76
Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement. Proc Natl Acad Sci U S A (1987) 2.62
Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. Science (1993) 2.36
CG dinucleotide clusters in MHC genes and in 5' demethylated genes. Nucleic Acids Res (1984) 1.90
The interleukin 1 gene is expressed by rat glomerular mesangial cells and is augmented in immune complex glomerulonephritis. J Immunol (1987) 1.80
Cell-surface engineering with GPI-anchored proteins. FASEB J (1996) 1.59
Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro. J Clin Invest (1988) 1.41
The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma. Mol Pathol (2000) 1.41
Directional antisense and sense cDNA cloning using Epstein-Barr virus episomal expression vectors. Gene (1989) 1.33
The gene encoding decay-accelerating factor (DAF) is located in the complement-regulatory locus on the long arm of chromosome 1. J Exp Med (1987) 1.29
Structure of a functional rabbit class I MHC gene: similarity to human class I genes. Immunogenetics (1985) 1.27
Use of an Epstein-Barr virus episomal replicon for anti-sense RNA-mediated gene inhibition in a human cytotoxic T-cell clone. Proc Natl Acad Sci U S A (1988) 1.15
Normal polymorphic variations and transcription of the decay accelerating factor gene in paroxysmal nocturnal hemoglobinuria cells. Proc Natl Acad Sci U S A (1988) 1.14
Expression of the imprinted H19 oncofetal RNA in epithelial ovarian cancer. Eur J Obstet Gynecol Reprod Biol (1999) 1.04
Properties of exogenously added GPI-anchored proteins following their incorporation into cells. J Cell Biochem (2001) 1.03
Protein kinase C isotypes in human erythroleukemia cell proliferation and differentiation. J Cell Sci (1992) 1.02
Gene therapy of murine teratocarcinoma: separate functions for insulin-like growth factors I and II in immunogenicity and differentiation. Proc Natl Acad Sci U S A (1994) 0.99
Developmentally imprinted genes as markers for bladder tumor progression. J Urol (1996) 0.95
Epstein-Barr virus episome-based promoter function in human myeloid cells. Nucleic Acids Res (1989) 0.94
CD8 functions as an inhibitory ligand in mediating the immunoregulatory activity of CD8+ cells. J Immunol (1990) 0.92
Hierarchical costimulator thresholds for distinct immune responses: application of a novel two-step Fc fusion protein transfer method. J Immunol (2000) 0.92
Protein transfer of preformed MHC-peptide complexes sensitizes target cells to T cell cytolysis. Immunity (1994) 0.92
Placental protein 14 functions as a direct T-cell inhibitor. Cell Immunol (1999) 0.92
Hematopoietic placental protein 14. An immunosuppressive factor in cells of the megakaryocytic lineage. Am J Pathol (1994) 0.91
A novel class of cell surface glycolipids of mammalian cells. Free glycosyl phosphatidylinositols. J Biol Chem (1996) 0.90
Rabbit class I MHC genes: cDNA clones define full-length transcripts of an expressed gene and a putative pseudogene. J Immunol (1984) 0.88
Glycosylphosphatidylinositol-modified murine B7-1 and B7-2 retain costimulator function. J Immunol (1995) 0.88
Differential effects of chondroitin sulfates A and B on monocyte and B-cell activation: evidence for B-cell activation via a CD44-dependent pathway. Blood (1998) 0.88
An immunoregulatory function for the CD8 molecule. Proc Natl Acad Sci U S A (1989) 0.85
Functional consequences of anti-sense RNA-mediated inhibition of CD8 surface expression in a human T cell clone. J Exp Med (1988) 0.83
In vitro attachment of glycosyl-inositolphospholipid anchor structures to mouse Thy-1 antigen and human decay-accelerating factor. Proc Natl Acad Sci U S A (1989) 0.83
Protein transfer of glycosyl-phosphatidylinositol (GPI)-modified murine B7-1 and B7-2 costimulators. J Immunother (1999) 0.82
A rheostatic mechanism for T-cell inhibition based on elevation of activation thresholds. Blood (2001) 0.82
Induction of antitumor immunity via intratumoral tetra-costimulator protein transfer. Cancer Res (2001) 0.82
Expression of glycoprotein gIII-human decay-accelerating factor chimera on the bovine herpesvirus 1 virion via a glycosyl phosphatidylinositol-based membrane anchor. J Virol (1993) 0.82
A receptor for the lipocalin placental protein 14 on human monocytes. FEBS Lett (1998) 0.81
Addition of lipid substituents of mammalian protein glycosylphosphoinositol anchors. Mol Cell Biol (1994) 0.81
Rabbit MHC antigens: occurrence of non-beta-2-microglobulin-associated class I molecules. Mol Immunol (1982) 0.80
Negative signaling by anti-HLA class I antibodies is dependent upon two triggering events. Int Immunol (1998) 0.80
CD40.FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism. Int Immunol (2007) 0.79
Regulation of allogeneic responses by expression of CD8 alpha chain on stimulator cells. Int Immunol (1990) 0.78
Glycosyl-phosphatidylinositol reanchoring unmasks distinct antigen-presenting pathways for CD1b and CD1c. J Immunol (2000) 0.78
Bone marrow stromal cell blockade of human leukemic cell differentiation. Blood (1994) 0.77
C-FMS dependent HL-60 cell differentiation and regulation of RB gene expression. J Cell Physiol (1993) 0.77
CTLA-4.FasL inhibits allogeneic responses in vivo. Cell Immunol (2006) 0.77
Gene therapy of rat brain glioblastoma by an episome-based transcriptional cassette expressing antisense IGF-I cDNA. Indian J Biochem Biophys (1994) 0.77
Functional dissociation of CD8 alpha's Ig homologue and connecting peptide domains. J Immunol (1996) 0.76
Alloantigenic recognition of artificial glycosyl phosphatidylinositol-anchored HLA-A2.1. Mol Immunol (1994) 0.75
Lessons to be learned from hematopoietic malignancies. Workshop report from the Division of Research Grants, National Institutes of Health. Am J Pathol (1995) 0.75
The expansion of human gammadelta T cells in response to Daudi cells requires the participation of CD4+ T cells. Immunology (1999) 0.75
alpha2-macroglobulin modulates the immunoregulatory function of the lipocalin placental protein 14. Biochem J (2000) 0.75
A glycosylphosphatidylinositol-anchored cytokine can function as an artificial cellular adhesin. Exp Cell Res (1994) 0.75
Amyloid precursor protein in cell cultures: a 130 kDa polypeptide. Prog Clin Biol Res (1989) 0.75
Antisense modulation of the ICAM-1 phenotype of a model human bone marrow stromal cell line. Exp Cell Res (1998) 0.75
Glycerolphosphoinositide anchors for membrane-tethering proteins. Methods Enzymol (2000) 0.75
Non-glycosylated human B7-1(CD80) retains the capacity to bind its counter-receptors. FEBS Lett (1998) 0.75